Advanced Enzyme Technologies Limited (Advanced Enzymes; NSE: ADVENZYMES; BSE: 540025), a leading specialty biotech company, announced their unaudited financial results for the second quarter and half year ended September 2026. The company reported a revenue of ₹ 2,145 million in Q2 FY27, marking a 16% year-on-year growth compared to ₹ 1,845 million in Q2 FY26. Moreover, the profit after tax (PAT) grew by 14% to ₹ 512 million in Q2 FY27 from ₹ 447 million in Q2 FY26.

Financial Highlights

The consolidated EBITDA during Q2 FY27 stood at ₹ 721 million, a 20% increase from ₹ 601 million in the same quarter of the previous year. The EBITDA margin improved to 34% compared to 33% in Q2 FY26. The earnings per share (EPS) also rose to ₹ 4.33 in Q2 FY27 from ₹ 3.87 in Q2 FY26.

Segmental Performance

The Human Nutrition segment recorded a 6% year-on-year growth to ₹ 1,285 million. The Animal Nutrition segment saw a significant 37% growth to ₹ 265 million. The Bio-Processing segment delivered robust performance with a 43% year-on-year increase to ₹ 365 million. The Specialized Manufacturing segment contributed 25% growth to ₹ 231 million.

Therefore, the company’s diversified segments are driving consistent growth, positioning Advanced Enzyme Technologies Limited for a strong future.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Advanced drops 16.7% over three months and trades near its 52-week lows. Premium net margins of 22.1% demonstrate strong cost discipline and a wide competitive moat. Not a single revenue dip or loss quarter in five years — this is a business built to last through cycles. The stock sits at 9% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 11.3% and profits at 16.9% CAGR, with D/E of 0.00. Meanwhile, the stock dips 16.7% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Advanced Enzyme Technologies Limited.

Ratnaveer Precision Engineering Limited (RATNAVEER) announced its unaudited consolidated financial results for the second quarter and half-year of FY27, reflecting robust performance. The company reported a 35% year-on-year increase in revenue, reaching ₹3,872.37 million, and a 56% year-on-year surge in profit after tax (PAT) to ₹240.63 million.

Operational Progress

The strong performance is a testament to the company’s operational progress across its diversified manufacturing verticals. Supported by its established export presence and strategic expansion into electronics-grade materials through its integrated FR-4 Copper Clad Laminate (CCL) project, the company continues to thrive.

Financial Highlights

Key financial highlights for Q2 FY27 include a total income of ₹3,928.41 million, up from ₹2,879.10 million in Q2 FY26, and total expenditure of ₹3,506.79 million, up from ₹2,575.64 million. The EBITDA margin improved to 10.89% from 10.62%, and the PAT margin rose to 6.21% from 5.40%.

Mr. Vijay R. Sanghavi, Managing Director, Ratnaveer Precision Engineering Limited, said: “We are pleased with the company’s performance and look forward to continued growth and innovation in the upcoming quarters.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Ratnaveer Precision Engineering Limited

Ratnaveer Precision Engineering Limited belongs to the Basic Materials › Steel sector. Here’s a quick read on where the business and the stock stand today.

Ratnaveer gains 89.8% over three months and trades near its 52-week highs. The PEG of 0.48 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Thin margins at 6.0% leave limited room for error — any demand softness or cost spike hits the bottom line hard. The stock trades at 94% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. Both the business and the stock move in the right direction. Revenue grows at 30.6%, profits at 36.9%, and the PEG sits at 0.48 — below its growth rate. That combination is rare. Check Fundamentals of Ratnaveer Precision Engineering Limited.

Aarti Industries Limited (AIL), a leading global speciality chemicals company, today announced its financial results for the second quarter and half-year ended September 30, 2026, reporting continued revenue and EBITDA growth, supported by higher volumes. The Company sustained its growth momentum, with volumes up by over 30%. Higher export demand and effective pass-through of elevated raw material costs drove revenue growth. Reflecting this growth, the quarterly EBITDA breached the 400 crore mark to close at 418 crore, the highest ever for AIL.

Financial Highlights

The company reported the following financial highlights for Q2 FY27:

Revenue from Operations: ₹3,887 crore, registering growth of 73% YoY and 48% QoQ.

EBITDA: ₹418 crore, compared with ₹291 crore in Q2 FY26, representing 44% YoY growth.

Profit After Tax: ₹169 crore, registering growth of 60% YoY.

Business Highlights & Outlook

The company expects to sustain its growth momentum, supported by export demand, progressing customer engagements, and the commercialisation of new capacities. It remains focused on improving asset utilisation, operating efficiency, working capital management, and cash generation, alongside developing value-added speciality chemical platforms.

Mr Suyog Kotecha, Managing Director & CEO, Aarti Industries Limited, said: “Over the past two years, our efforts have been directed towards strengthening the foundations for AIL’s next phase of growth. We have focused on expanding market participation, deepening customer partnerships, and building capabilities that let us serve a wider range of global requirements. These efforts are now driving stronger business momentum. As global supply chains evolve, customers are placing increasing importance on reliability, technical depth, and long-term manufacturing partnerships. We intend to pursue growth with the same emphasis on consistency, capital efficiency and long-term value creation.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Aarti Industries Limited

Aarti Industries Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Aarti holds in the upper half of its 52-week range, a sign the market backs the stock. Thin margins at 5.9% leave limited room for error — any demand softness or cost spike hits the bottom line hard. No meaningful dividend — total return is entirely dependent on capital appreciation. The stock trades at 77% of its 52-week range — near its best levels of the year. Clearly, the market pays a premium for this name. Price climbs recently despite 7.9% revenue growth and a PEG of 99.00. Consequently, either institutions position ahead of improvement or the move fades when earnings disappoint. Treat this as a trading signal, not an investment thesis. Check Fundamentals of Aarti Industries Limited.